AnalystsJonathan WollebenJonathan Wolleben's Stock Forecasts
AnalystsJonathan Wolleben
Sectors:
Industries:
Analyst Ranking
Top 13%
#581 out of 4595 analysts
Average Return
+7.71%
Win Rate
38%52 out of 136
Risk vs Reward
Poor
Good
Jonathan Wolleben's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Madrigal Pharmaceuticals IncMDGL | +365.01% | $64.44 | $299.65 | 2022-05-10 - 2023-05-09 | Buy |
Pharvaris NvPHVS | +206.28% | $8.12 | $24.87 | 2023-02-27 - 2024-02-26 | Buy |
Pharvaris NvPHVS | +198.29% | $8.75 | $26.10 | 2023-01-11 - 2024-01-10 | Buy |
Pharvaris NvPHVS | +194.90% | $8.62 | $25.42 | 2022-12-09 - 2023-12-08 | Buy |
Proqr Therapeutics NvPRQR | +188.44% | $0.79 | $2.27 | 2022-04-14 - 2023-04-13 | Buy |
Jonathan Wolleben Analyst Color
Get additional color on Jonathan Wolleben's coverage of popular stocks
Jonathan Wolleben's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Larimar Therapeutics IncLRMR | 11 | Buy | $25.00 | +212.50% | Reiterates | 3 days ago |
Sagimet Biosciences IncSGMT | 6 | Buy | $48.00 | +800.56% | Reiterates | 10 days ago |
Structure Therapeutics IncGPCR | 5 | Buy | $91.00 | +166.08% | Reiterates | 24 days ago |
Crinetics Pharmaceuticals IncCRNX | 10 | Buy | $80.00 | +80.14% | Reiterates | 24 days ago |
Altimmune IncALT | 9 | Buy | $24.00 | +219.57% | Maintains | 24 days ago |
Mirum Pharmaceuticals IncMIRM | 7 | Buy | $66.00 | +174.66% | Maintains | 25 days ago |
Protagonist Therapeutics IncPTGX | 7 | Buy | $45.00 | +59.86% | Maintains | a month ago |
Ocular Therapeutix IncOCUL | 14 | Buy | $22.00 | +285.96% | Maintains | a month ago |
Madrigal Pharmaceuticals IncMDGL | 7 | Buy | $381.00 | +61.33% | Maintains | a month ago |
Biocryst Pharmaceuticals IncBCRX | 3 | Buy | $15.00 | +132.20% | Maintains | a month ago |
Savara IncSVRA | 4 | Buy | $8.00 | +95.60% | Reiterates | a month ago |
Rallybio CorpRLYB | 11 | Buy | $8.00 | +379.04% | Reiterates | a month ago |
Pharvaris NvPHVS | 9 | Buy | $50.00 | +163.71% | Maintains | 2 months ago |
Spruce Biosciences IncSPRB | 6 | Buy | $3.00 | +304.86% | Maintains | 3 months ago |
Clearside Biomedical IncCLSD | 8 | Buy | $5.00 | +257.14% | Reiterates | 3 months ago |
Allakos IncALLK | 4 | Buy | $3.00 | +140.00% | Maintains | 5 months ago |
Aura Biosciences IncAURA | 4 | Buy | $19.00 | +158.50% | Maintains | 7 months ago |
Dbv Technologies SaDBVT | 7 | Buy | $4.00 | +614.29% | Reiterates | 10 months ago |
Proqr Therapeutics NvPRQR | 4 | Buy | $6.00 | N/A | Reiterates | a year ago |
Warner Music Group CorpWMG | 1 | Buy | $24.00 | N/A | Maintains | a year ago |
Strongbridge Biopharma PLCSBBP | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.